Rahul Rao is a freelance science writer, graduate of New York University’s Science, Health and Environmental Reporting Program, and “Doctor Who” fan.
![headshot of Rahul Rao](https://www.thetransmitter.org/wp-content/uploads/2021/05/Rahul-Rao-head-Cropped.jpg)
Rahul Rao
From this contributor
Web app tracks pupil size in people, mice
The app relies on artificial intelligence and could help researchers standardize studies of pupil differences in autistic people and in mouse models of autism.
New library catalogs the human gut microbiome
Researchers put hundreds of gut bacteria strains through their paces to chart the compounds each creates — and to help others explore the flora's potential contribution to autism.
New unified toolbox traces, analyzes neurons
‘SNT’ helps researchers sift through microscope images to reconstruct and analyze neurons and their connections.
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.